SCHEMBL3236140

SCHEMBL3236140

[CH2]c1ccc(CNC(CO)Cc2cccc(OCc3ccccc3Cl)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ TP53 P04637 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ NR4A2 P43354 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ CD274 Q9NZQ7 2/20 0.41
▸ SPHK2 Q9NRA0 1/20 0.41
▸ SPHK1 Q9NYA1 1/20 0.41
▸ MAOB P27338 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ SLC2A1 P11166 1/20 0.40
▸ BCHE P06276 1/20 0.38
▸ PDCD1 Q15116 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3245805 0.76 SMN1; SMN2 (0.41) CYP1A2CYP3A4CYP2D6CYP2C19MAPT
SCHEMBL3236145 0.74 NPC1 (0.46) CYP1A2CYP3A4CYP2D6CYP2C19NPC1
SCHEMBL7044167 0.72 CA2 (0.52) GAACD274PDCD1
SCHEMBL7044169 0.72 CA2 (0.52) GAACD274PDCD1
SCHEMBL964385 0.71 MAOB (0.59) NPC1NR4A2RAB9ACD274MAOB
SCHEMBL4490949 0.71 NR1H2 (0.38) CYP1A2CYP3A4CYP2D6CYP2C19TP53
SCHEMBL18127230 0.70 BCHE (0.57) MAOBMEN1KMT2ASLC2A1BCHE
SCHEMBL6408450 0.69 NR4A2 (0.61) CYP1A2CYP3A4CYP2D6CYP2C19TP53
SCHEMBL10435998 0.68 TP53 (0.60) CYP1A2CYP3A4CYP2D6CYP2C19TP53
SCHEMBL8985630 0.68 TP53 (0.58) CYP1A2CYP3A4CYP2D6CYP2C19TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100144733-A1 Compounds, compositions and methods comprising heteroaromatic derivatives INSTITUTE FOR ONEWORLD HEALTH 2010-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144733-A1 Compounds, compositions and methods comprising heteroaromatic derivatives CFTR, PKD1, PKD2 CYP1A2 2249/4885CYP3A4 1541/4885CYP2D6 1205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback